Urine liver fatty acid binding protein and chronic kidney disease progression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urine liver fatty acid binding protein and chronic kidney disease progression
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
Volume 77, Issue 7, Pages 549-554
Publisher
Informa UK Limited
Online
2017-07-27
DOI
10.1080/00365513.2017.1355561
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression
- (2017) Chi-yuan Hsu et al. KIDNEY INTERNATIONAL
- Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study
- (2016) Kathleen D. Liu et al. PLoS One
- Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial
- (2015) Kenichi Tanaka et al. Clinical and Experimental Nephrology
- Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD
- (2015) Katsuomi Matsui et al. Clinical and Experimental Nephrology
- Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study
- (2015) M. C. Foster et al. Clinical Journal of the American Society of Nephrology
- Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study
- (2014) Roberto Minutolo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
- (2014) Gudeta D. Fufaa et al. DIABETOLOGIA
- Timing of Arteriovenous Fistula Placement: Keeping It in Perspective
- (2014) B. S. Dixon JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Urinary liver type fatty acid binding protein in diabetic nephropathy
- (2013) Atsuko Kamijo-Ikemori et al. CLINICA CHIMICA ACTA
- NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction
- (2013) Leon Holzscheiter et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Urinary Liver-Type Fatty Acid-Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
- (2013) N. M. Panduru et al. DIABETES CARE
- Clinical Value of NGAL, L-FABP and Albuminuria in Predicting GFR Decline in Type 2 Diabetes Mellitus Patients
- (2013) Kuei-Mei Chou et al. PLoS One
- Predictive Effects of Urinary Liver-Type Fatty Acid-Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
- (2012) S.-i. Araki et al. DIABETES CARE
- Notice
- (2012) Kidney International Supplements
- Prognostic Role of Ambulatory Blood Pressure Measurement in Patients With Nondialysis Chronic Kidney Disease
- (2011) Roberto Minutolo et al. ARCHIVES OF INTERNAL MEDICINE
- Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis
- (2011) Shan Mou et al. CLINICA CHIMICA ACTA
- Additional renoprotective effects of azelnidipine combined with angiotensin receptor blockers in patients with diabetic nephropathy
- (2011) T. Nakamura et al. CLINICAL NEPHROLOGY
- Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria
- (2011) Tsukasa Nakamura et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy
- (2011) Stine E. Nielsen et al. KIDNEY INTERNATIONAL
- Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
- (2010) S. E. Nielsen et al. DIABETES CARE
- Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease
- (2010) Tsukasa Nakamura et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy
- (2010) Tsukasa Nakamura et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition
- (2009) S. E. Nielsen et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation